Press release
Top Factor Driving Xerostomia Therapeutics Market Growth in 2025: Chemotherapy's Role In Driving The Growth Of Xerostomia Therapeutics Market
Xerostomia Therapeutics
The increasing adoption of chemotherapy in cancer treatment is expected to boost the growth of the xerostomia therapeutics market. Chemotherapy, which uses powerful medications to kill or slow the growth of cancer cells, can often cause side effects such as xerostomia, or dry mouth. Xerostomia therapeutics include treatments like saliva-stimulating medications or mouth rinses that help manage the condition, improving patients' ability to eat and maintain adequate nutrition. According to the National Cancer Institute, there are currently 18.1 million cancer survivors in the U.S., and this number is expected to increase to 22.5 million by 2032, a 24.4% rise. As chemotherapy treatments continue to increase, so does the need for xerostomia therapeutics.
Get Your Xerostomia Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/xerostomia-therapeutics-global-market-report
What growth opportunities are expected to drive the xerostomia therapeutics market's CAGR through 2034?
The xerostomia therapeutics market has expanded significantly in recent years. It is set to grow from $2.14 billion in 2024 to $2.26 billion in 2025, reflecting a CAGR of 5.7%. Factors contributing to past growth include a higher incidence of xerostomia in elderly populations, advancements in research and product development, greater awareness of xerostomia treatments, an increase in medical conditions, and the growing prevalence of chronic diseases.
The xerostomia therapeutics market is projected to grow steadily, reaching $2.79 billion by 2029 with a CAGR of 5.3%. Growth in this sector will be driven by the availability of affordable medications, a higher prevalence of oral health conditions, growing awareness among healthcare professionals, government initiatives, and an increase in medication use. Key trends include the development of artificial saliva and saliva substitutes, technological innovations, the rise of personalized medicine and targeted therapies, telehealth and remote monitoring solutions, and the emergence of non-invasive treatment options.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15700&type=smp
What are the emerging trends shaping the future of the xerostomia therapeutics market?
Leading companies in the xerostomia therapeutics market are focusing on developing patient-friendly, non-invasive treatments like oral sprays to meet the demand for convenient and effective dry mouth management solutions. Oral sprays deliver targeted moisture and lubrication directly to the affected areas in the mouth, providing effective relief. For example, in July 2023, K Pharmaceuticals, an India-based pharmaceutical company, launched Aquoral, a clinically proven oral spray designed to treat dry mouth (xerostomia). Caused by various factors like medications and diseases, xerostomia can result in discomfort and difficulty in chewing and swallowing. Aquoral offers up to six hours of sustainable relief by forming a protective barrier in the oral cavity, reducing moisture loss, and improving comfort. Unlike traditional aqueous treatments that require frequent reapplication, Aquoral uses a patented plant-derived lipid-based technology, Oxidized Glycerol Triesters (OGT), for superior protection.
Which growth-oriented segments of the xerostomia therapeutics market are leading the industry's development?
The xerostomia therapeutics market covered in this report is segmented -
1) By Type: Artificial Saliva Or Saliva Substitutes, Salivary Stimulants
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, Hypermarkets And Supermarkets
3) By End-User: Adult, Pediatric
Subsegments:
1) By Artificial Saliva Or Saliva Substitutes: Oral Sprays, Gels, Lozenges, Mouthwashes
2) By Salivary Stimulants: Prescription Drugs, Over-The-Counter (Otc) Products, Chewing Gums And Lozenges
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15700
What regions are leading the charge in the xerostomia therapeutics market?
North America was the largest region in the xerostomia therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xerostomia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the xerostomia therapeutics market?
Major companies operating in the xerostomia therapeutics market are Bayer AG, 3M Company, GlaxoSmithKline plc, Colgate-Palmolive Company, Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Church & Dwight* Co. Inc., Cipla Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Synedgen Inc., Sunstar Suisse S.A., Advanz Pharma Corp., Pharmascience Inc., Mission Pharmacal Company, Dentaid Ltd., Cyclacel Pharmaceuticals Inc., Parnell Pharmaceuticals Holdings Ltd., Teva Pharmaceutical Industries Ltd., Forward Science Holding Inc., ICPA Health Products Ltd., CCMed Ltd., Bio Cosmetics Laboratories S.L., Quest Products LLC, Acacia Pharma, Saliwell Limited, OraCoat, Oralieve UK Ltd., OraPharma Inc., OraVital Inc
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15700&type=smp
What Is Covered In The Xerostomia Therapeutics Global Market Report?
•Market Size Forecast: Examine the xerostomia therapeutics market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the xerostomia therapeutics market for a structured understanding.
•Key Players Overview: Analyze major players in the xerostomia therapeutics market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the xerostomia therapeutics market.
•Segment Contributions: Evaluate how different segments drive overall growth in the xerostomia therapeutics market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the xerostomia therapeutics market.
•Industry Challenges: Identify potential risks and obstacles affecting the xerostomia therapeutics market.
•Competitive Landscape: Review strategic developments in the xerostomia therapeutics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Top Factor Driving Xerostomia Therapeutics Market Growth in 2025: Chemotherapy's Role In Driving The Growth Of Xerostomia Therapeutics Market here
News-ID: 3945459 • Views: …
More Releases from The Business Research Company
Analysis of Key Market Segments Driving the Occupant Classification System Marke …
Understanding the occupant classification system market reveals important insights into automotive safety technology and its rapid evolution. This sector is poised for significant growth as vehicle manufacturers and suppliers focus on enhancing passenger protection, adapting to new vehicle types, and integrating cutting-edge sensing technologies. Below is a detailed overview of the market's size, key players, driving trends, and segmentation.
Projected Market Size and Growth of the Occupant Classification System Market
The…
Leading Companies Fueling Innovation and Growth in the Mountain Electric Bikes M …
The mountain electric bikes market is set to experience significant expansion over the coming years, driven by advancements in technology and growing consumer interest in sustainable and versatile mobility options. As the outdoor and e-mobility sectors continue to evolve, this market offers promising opportunities for manufacturers and riders alike. Let's explore the market size projections, leading players, future trends, and detailed segment analysis shaping this industry.
Mountain Electric Bikes Market Size…
Market Trend Analysis: The Impact of Recent Innovations on the Motorhome Vehicle …
The motorhome vehicle market is on track for impressive growth in the coming years, driven by evolving travel preferences and technological advancements. As more people seek flexible and sustainable travel options, this sector is becoming increasingly attractive to consumers and businesses alike. Let's explore the market's size projections, key players, emerging trends, and the various segments shaping its future.
Projected Growth and Market Size of the Motorhome Vehicle Market
The motorhome…
Key Strategic Factors and Emerging Trends Shaping the Motorcycle Chain Sprocket …
The motorcycle chain sprocket market is set for significant expansion as demand rises for more durable and efficient motorcycle components. As motorcycle technologies evolve and the global fleet grows, the market outlook for chain sprockets reflects promising growth opportunities heading toward 2030. This overview explores market size projections, influential players, key trends, and segment dynamics shaping the motorcycle chain sprocket industry.
Forecasted Growth and Market Size of the Motorcycle Chain Sprocket…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
